{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T15:17:00Z","timestamp":1777130220984,"version":"3.51.4"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[2005,5]]},"abstract":"<jats:p>\n            <jats:bold>\n              <jats:italic>Background and Purpose\u2014<\/jats:italic>\n            <\/jats:bold>\n            The detailed role of angiotensin II in salt-exacerbated stroke is unclear. We examined the role of angiotensin II in salt-accelerated stroke of stroke-prone spontaneously hypertensive rats (SHRSP).\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Methods\u2014<\/jats:italic>\n            <\/jats:bold>\n            Salt-loaded SHRSP were orally given the angiotensin II type 1 (AT1) receptor blocker candesartan (0.3 to 3 mg\/kg per day) and calcium channel blocker amlodipine (1 mg\/kg per day), and the effects on stroke (n=61) and brain superoxide were compared between them. We also examined the effect of angiotensin II infusion (200 ng\/kg per min) on brain superoxide production and blood\u2013brain barrier.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Results\u2014<\/jats:italic>\n            <\/jats:bold>\n            Despite the comparable hypotensive effect between candesartan and amlodipine, candesartan prolonged survival of salt-loaded SHRSP much more than amlodipine (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.01), being associated with more improvement of cerebral arteriolar thickening, cerebral arteriolar cell proliferation, and hippocampal CA1 neuronal cell reduction (1024.9\u00b120.6 versus 724.9\u00b122.8 cells\/mm\n            <jats:sup>2<\/jats:sup>\n            ;\n            <jats:italic>P<\/jats:italic>\n            &lt;0.01; n=7 to 10 in each group) in SHRSP by candesartan (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05) than amlodipine. Salt loading increased superoxide and NADPH oxidase activity in brain cortex and hippocampus of SHRSP, and this increase was prevented by candesartan (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.01) but not amlodipine. Angiotensin II infusion, via AT1 receptor, directly increased brain superoxide by 1.8-fold (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05; n=6 to 7 in each group) and impaired blood\u2013brain barrier in salt-loaded SHRSP by 1.7-fold (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05), and this increase in brain superoxide and blood\u2013brain barrier impairment was prevented by tempol as well as candesartan.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Conclusion\u2014<\/jats:italic>\n            <\/jats:bold>\n            Excess salt, via oxidative stress, accelerates stroke, and angiotensin II, via AT1 receptor, plays a pivotal role in brain superoxide production of SHRSP by excess salt.\n          <\/jats:p>","DOI":"10.1161\/01.str.0000163084.16505.e3","type":"journal-article","created":{"date-parts":[[2005,4,8]],"date-time":"2005-04-08T00:44:39Z","timestamp":1112921079000},"page":"1077-1082","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":82,"title":["Critical Role of Angiotensin II in Excess Salt-Induced Brain Oxidative Stress of Stroke-Prone Spontaneously Hypertensive Rats"],"prefix":"10.1161","volume":"36","author":[{"given":"Shokei","family":"Kim-Mitsuyama","sequence":"first","affiliation":[{"name":"From the Department of Pharmacology and Molecular Therapeutics (S.K.-M., E.Y., T.T.), Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan; and Departments of Pharmacology (Y.Z., Y. Izumi, Y. Izumiya, T.I., H.I.) and Pathology (H.W.), Osaka City University Graduate School of Medical Science, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology and Molecular Therapeutics (S.K.-M., E.Y., T.T.), Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan; and Departments of Pharmacology (Y.Z., Y. Izumi, Y. Izumiya, T.I., H.I.) and Pathology (H.W.), Osaka City University Graduate School of Medical Science, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Tanaka","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology and Molecular Therapeutics (S.K.-M., E.Y., T.T.), Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan; and Departments of Pharmacology (Y.Z., Y. Izumi, Y. Izumiya, T.I., H.I.) and Pathology (H.W.), Osaka City University Graduate School of Medical Science, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumei","family":"Zhan","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology and Molecular Therapeutics (S.K.-M., E.Y., T.T.), Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan; and Departments of Pharmacology (Y.Z., Y. Izumi, Y. Izumiya, T.I., H.I.) and Pathology (H.W.), Osaka City University Graduate School of Medical Science, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasukatsu","family":"Izumi","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology and Molecular Therapeutics (S.K.-M., E.Y., T.T.), Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan; and Departments of Pharmacology (Y.Z., Y. Izumi, Y. Izumiya, T.I., H.I.) and Pathology (H.W.), Osaka City University Graduate School of Medical Science, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Izumiya","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology and Molecular Therapeutics (S.K.-M., E.Y., T.T.), Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan; and Departments of Pharmacology (Y.Z., Y. Izumi, Y. Izumiya, T.I., H.I.) and Pathology (H.W.), Osaka City University Graduate School of Medical Science, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Ioroi","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology and Molecular Therapeutics (S.K.-M., E.Y., T.T.), Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan; and Departments of Pharmacology (Y.Z., Y. Izumi, Y. Izumiya, T.I., H.I.) and Pathology (H.W.), Osaka City University Graduate School of Medical Science, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Wanibuchi","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology and Molecular Therapeutics (S.K.-M., E.Y., T.T.), Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan; and Departments of Pharmacology (Y.Z., Y. Izumi, Y. Izumiya, T.I., H.I.) and Pathology (H.W.), Osaka City University Graduate School of Medical Science, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Iwao","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology and Molecular Therapeutics (S.K.-M., E.Y., T.T.), Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan; and Departments of Pharmacology (Y.Z., Y. Izumi, Y. Izumiya, T.I., H.I.) and Pathology (H.W.), Osaka City University Graduate School of Medical Science, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","first-page":"I-143","volume":"33","year":"1974","unstructured":"Okamoto K, Yamori Y, Nagaoka A. Establishment of the stroke-prone spontaneously hypertensive rats (SHR). Circ Res. 1974; 33\/34: I-143\u2013I-153.","journal-title":"Circ Res"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440420077006"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)01463-8"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199301000-00006"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.29.8.1671"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.24.2.8421827"},{"key":"e_1_3_2_7_2","first-page":"11","volume":"52","year":"2000","unstructured":"Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev. 2000; 52: 11\u201334.","journal-title":"Pharmacol Rev"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.33.3.862"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.92.1.88"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.30.5.1054"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.26.1.199"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.34.3.496"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.11.1.8018341"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.33.1.424"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0270(94)00172-D"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.0000100665.67510.f5"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117637"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.9942"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.18-20-08292.1998"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200018100-00010"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199816100-00017"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.34.4.943"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118623"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.86.5.494"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.95.3.588"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08089-3"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200305000-00011"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.STR.0000163084.16505.e3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T21:49:14Z","timestamp":1715550554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.STR.0000163084.16505.e3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["10.1161\/01.STR.0000163084.16505.e3"],"URL":"https:\/\/doi.org\/10.1161\/01.str.0000163084.16505.e3","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"2004-12-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-02-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-04-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}